All stock lists
Unlock the score
TransMedics Group, Inc. (NASDAQ:TMDX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
71.35+0.61 (+0.86%)
Market cap
$2.47B
Insider Score
Analyst consensus
Listed since
May 2, 2019
Website
Insider Score
/ 100
TMDX Insider Score
TransMedics Group, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
TMDX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 189.95 M | 173.93 M | 160.76 M | 143.82 M | 157.37 M | 143.54 M |
| Revenue Growth (YoY) | 20.70 % | 21.18 % | 32.18 % | 32.24 % | 37.68 % | 48.21 % |
| Cost of Revenue | 76.75 M | 72.77 M | 67.35 M | 59.25 M | 60.78 M | 55.31 M |
| Gross Profit | 113.20 M | 101.16 M | 93.41 M | 84.58 M | 96.59 M | 88.23 M |
| SG&A Expense | 57.83 M | 56.92 M | 51.44 M | 46.02 M | 44.09 M | 43.63 M |
| R&D Expense | 31.63 M | 24.88 M | 20.70 M | 15.26 M | 15.93 M | 17.16 M |
| Operating Expenses | 89.46 M | 87.86 M | 72.14 M | 61.27 M | 60.02 M | 60.78 M |
| Operating Income | 23.74 M | 13.30 M | 21.27 M | 23.30 M | 36.57 M | 27.44 M |
| Pretax Income | 19.41 M | 8.48 M | 21.63 M | 23.03 M | 36.18 M | 26.68 M |
| Tax Provision | 4.72 M | 1.17 M | -83.75 M | -1.29 M | 1.27 M | 994.00 K |
| Net Income | 14.68 M | 7.32 M | 105.38 M | 24.32 M | 34.91 M | 25.68 M |
| EPS (Basic) | 0.42 | 0.21 | 3.08 | 0.71 | 1.03 | 0.76 |
| EPS (Diluted) | 0.41 | 0.20 | 2.59 | 0.66 | 0.92 | 0.70 |
| Shares Outstanding | 34.58 M | 34.38 M | 34.22 M | 34.11 M | 33.91 M | 33.72 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.